Strasbourg Europe Cancer Institute

What Strasbourg Europe Cancer Institute does

Institut Strauss is a French public healthcare establishment (établissement hospitalier public) operating as the regional cancer center for Strasbourg and the Alsace region, delivering comprehensive oncology services under a 100%-oncology mandate. It is a member of UNICANCER, the national federation of French cancer treatment centers, which provides access to national clinical trial networks and shared research resources. The institute provides the full spectrum of cancer care including screening, oncogenetics, diagnostic imaging, nuclear medicine, chemotherapy, surgery, radiotherapy, internal vectorized radiotherapy, hormone therapy, immunotherapy, and targeted therapies, complemented by supportive care and post-cancer follow-up.

The institution combines patient care with a multi-modal research program covering clinical research (including an early-phase trials unit), fundamental research, translational research, and data research. Specialized research assets include a Nanomedicine Laboratory focused on enhancing immunotherapy effectiveness against solid tumors, and the Biological Resources Center in Cancerology (CRBC), which manages biological sample collections for cancer research. The institute also fulfills a teaching mission, training future oncologists through university affiliations.

The business model rests on three pillars: reimbursement from the French national health insurance system (Sécurité sociale) for medical procedures, public and European research grants (including ERC funding for projects such as Nano-BITE), and donations through a dedicated philanthropy program. Patients access care through medical referrals or self-referral via online appointment scheduling and a patient imaging portal. The institute maintains the ICANS facility in Strasbourg and pursues strategic research partnerships with leading French and European institutions including Gustave Roussy.

Name

Strasbourg Europe Cancer Institute

Legal name

Institut Strauss

Website

https://centre-paul-strauss.fr

Company type

Private

Founded year

1923

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Strasbourg Europe Cancer Institute (Institut Strauss) is a French public cancer center in Strasbourg, dedicated 100% to oncology, providing comprehensive cancer care, clinical research, and teaching across the Alsace region as a UNICANCER member.

Ownership category

akta.pro rank

Product category

Cancer Treatment Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (62211)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB)

Keywords

• Oncology treatment services
• Cancer care center
• Radiation therapy
• Clinical cancer research
• Nuclear medicine services

Headquarters

HQ city

Strasbourg

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Public Healthcare Reimbursement: As a French public healthcare establishment, the institute generates revenue through reimbursement from the French national health insurance system (Sécurité sociale) for medical procedures and treatments provided to patients.
2. Clinical Research Grants: Funding from national and European research grants including ERC (European Research Council) grants for conducting clinical trials and fundamental research.
3. Donations and Patronage: The institute accepts public donations through its dedicated donation page and receives support via heritage transfers and charitable contributions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Institut Strauss is a French public hospital establishment 100% dedicated to oncology, serving as the cancer treatment center for Strasbourg and the Alsace region. It provides comprehensive cancer care including screening, oncogenetics, diagnostic imaging, nuclear medicine, surgery, radiotherapy (including internal vectorized radiotherapy), chemotherapy, immunotherapy, hormone therapy, and targeted therapies, along with supportive care, clinical trials, and post-treatment follow-up. The institute also conducts clinical, fundamental, translational, and data research, and operates specialized facilities such as the Nanomedicine Laboratory and the Biological Resources Center in Cancerology (CRBC).

Product overview

The Institut Strauss is a comprehensive cancer center (Centre de lutte contre le cancer) providing 100% dedicated oncology services. It operates as a unified healthcare facility offering integrated cancer care through multiple treatment modalities including medical oncology, surgical oncology, radiotherapy, nuclear medicine, immunotherapy, hormone therapy, and targeted therapies. The institute also provides supportive care, oncogenetics counseling, diagnostic imaging, and clinical trials. The institution combines patient care with clinical research, fundamental research, translational research, and university teaching as part of its multi-mission approach under the UNICANCER federation.

Differentiator

Problem solved

Functional benefit

Products and services

• Comprehensive Cancer Care Services Integrated cancer care for patients at all stages, from screening and diagnosis through treatment (chemotherapy, surgery, radiotherapy, nuclear medicine, immunotherapy, targeted therapies, hormone therapy) and post-cancer follow-up, combined with supportive care and clinical trial access.
• Diagnostic Imaging and Oncogenetics Cancer screening, diagnostic imaging, nuclear medicine examinations, and oncogenetics counseling for patients and families at risk of hereditary cancers.
• Clinical Trials Program Clinical research trials including early-phase oncology studies offered to eligible patients, integrated with patient care through the Clinical Research Unit (URC).
• Supportive Care and Patient Accompaniment Supportive care including psychosocial support, palliative care, and accompaniment services for cancer patients and their families throughout the care journey.
• Biological Resources Center in Cancerology (CRBC) Biological sample collection, storage, and management for translational and fundamental cancer research.
• University Teaching and Medical Training University-level medical education, conferences, scientific seminars, and professional training programs for oncologists and healthcare professionals.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• UNICANCERcoreStrategic or Co-development PartnerInstitut Strauss is a member of UNICANCER, the national federation of cancer treatment centers in France. This partnership provides access to national clinical trial networks, shared research resources, and best practices across the federation.
• Gustave RoussycoreStrategic or Co-development PartnerResearch partnership with Gustave Roussy, a leading French cancer research institute. Alexandre Detappe serves as both responsible for the nanomedicine laboratory at Institut Strauss and leads the Nanomedicine team at Gustave Roussy, enabling collaborative research in immunotherapy enhancement through nanomedicine.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strasbourg Europe Cancer Institute